Image

Biofilm on Chest Drains After Thoracic Surgery: Clinical Impact and Antibiotic Resistance

Biofilm on Chest Drains After Thoracic Surgery: Clinical Impact and Antibiotic Resistance

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This prospective observational study aims to investigate the frequency and clinical significance of biofilm formation on thoracic chest drains used after thoracic surgery. Biofilms are structured bacterial communities that adhere to surfaces and can promote infection and antibiotic resistance. In this study, small samples from the tips of chest drains will be collected under sterile conditions at the time of drain removal and analyzed in the microbiology laboratory.

The main objectives are to evaluate the relationship between the duration of chest drain placement and the presence of biofilm, and to identify the antibiotic resistance profiles of microorganisms isolated from these biofilms. Secondary outcomes include the association between biofilm formation, postoperative infections (such as empyema or wound infection), and the length of hospital stay.

This study will be conducted at Ondokuz Mayıs University Faculty of Medicine, Department of Thoracic Surgery, in collaboration with the Department of Microbiology. The findings are expected to contribute to better understanding of optimal drain management and infection prevention strategies after thoracic surgery.

Eligibility

Inclusion Criteria:

  • Age 18 years and older
  • Undergoing elective thoracic surgery requiring chest drain placement
  • Able and willing to provide written informed consent

Exclusion Criteria:

  • Presence of active infection prior to surgery
  • Emergency thoracic surgery
  • Immunosuppressed patients (e.g., neutropenia, advanced malignancy, organ transplantation)
  • Patients receiving systemic antibiotic therapy at the time of drain removal
  • Drainage for empyema or pre-existing pleural infection
  • Presence of extrathoracic infection focus
  • Refusal or inability to provide informed consent

Study details
    Biofilms
    Thoracic Surgery
    Postoperative Infection
    Antibiotic Resistance
    Bacterial

NCT07228598

Caner İşevi, MD

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.